BIORCHESTRA Co., Ltd.
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
BIORCHESTRA Expands Executive Leadership Team with the Appointment of David Oxley as Chief Business Officer 2023-04-05 20:00
BIORCHESTRA receives Citation from the Korean Minister of Trade, Industry, and Energy 2022-12-15 21:00
BIORCHESTRA announces that BMD-001 reduces Amyloid-β and Tau in non-human primate animal model of Alzheimer's Disease at the RNA Leaders USA Conference in Boston 2022-11-08 15:30
BIORCHESTRA appointed Dr. Gabriel Helmlinger (Ph.D., DABT) as Head of Translational and Clinical Pharmacology, Toxicology 2022-08-23 20:00
BIORCHESTRA Participated in Formulation and Delivery 2022-05-12 21:00
BIORCHESTRA, SK Biopharmaceuticals collaborate to develop miRNA-targeted therapeutics 2022-01-05 08:07
BIORCHESTRA appoints pharma veteran and Moderna and Akcea (Ionis) CMO "Dr. Louis St. L. O'Dea" as CMO of BIORCHESTRA 2021-09-23 20:00
1